Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Hospice and Anticancer Therapy—Shifting From an Either/or to a Both/and Treatment Model

Hospice and Anticancer Therapy—Shifting From an Either/or to a Both/and Treatment Model Opinion EDITORIAL Hospice and Anticancer Therapy— Shifting From an Either/or to a Both/and Treatment Model Tracy A. Balboni, MD, MPH Hospice is specialized interdisciplinary care for persons with 13 000 veterans with stage IV lung cancer uses the setting es- tablished by the VA Comprehensive End-of-Life Care Initia- terminal illness that—in contrast to the medical goals of cur- ing or slowing disease—aims to uphold quality of life by ad- tive (CELCI). The CELCI enables veterans to concurrently en- dressing the physical, psychosocial, and spiritual aspects of roll in hospice while receiving ongoing disease-directed illness. The hospice move- therapies. The degree of access to hospice care, and therefore ment began more than 50 opportunity for concurrent care, varied for each VA medical Related article page 810 years ago when Dame Cicely center from 2006 to 2012, creating an opportunity to exam- Saunders created the first modern hospice center in 1967, at ine the increasing availability of hospice that permits concur- St Christopher’s Hospice in London. In the United States, the rent hospice care and medical care. The authors examine in- Medicare Hospice Benefit was established in 1982, providing creasing quintiles of hospice availability and patient receipt of hospice coverage to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Hospice and Anticancer Therapy—Shifting From an Either/or to a Both/and Treatment Model

JAMA Oncology , Volume 5 (6) – Jun 28, 2019

Loading next page...
 
/lp/american-medical-association/hospice-and-anticancer-therapy-shifting-from-an-either-or-to-a-both-Ye7JlVl2tj

References (6)

Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2019.0079
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL Hospice and Anticancer Therapy— Shifting From an Either/or to a Both/and Treatment Model Tracy A. Balboni, MD, MPH Hospice is specialized interdisciplinary care for persons with 13 000 veterans with stage IV lung cancer uses the setting es- tablished by the VA Comprehensive End-of-Life Care Initia- terminal illness that—in contrast to the medical goals of cur- ing or slowing disease—aims to uphold quality of life by ad- tive (CELCI). The CELCI enables veterans to concurrently en- dressing the physical, psychosocial, and spiritual aspects of roll in hospice while receiving ongoing disease-directed illness. The hospice move- therapies. The degree of access to hospice care, and therefore ment began more than 50 opportunity for concurrent care, varied for each VA medical Related article page 810 years ago when Dame Cicely center from 2006 to 2012, creating an opportunity to exam- Saunders created the first modern hospice center in 1967, at ine the increasing availability of hospice that permits concur- St Christopher’s Hospice in London. In the United States, the rent hospice care and medical care. The authors examine in- Medicare Hospice Benefit was established in 1982, providing creasing quintiles of hospice availability and patient receipt of hospice coverage to

Journal

JAMA OncologyAmerican Medical Association

Published: Jun 28, 2019

There are no references for this article.